Compare DYN & MIAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DYN | MIAX |
|---|---|---|
| Founded | 1984 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.8B |
| IPO Year | 2020 | 2025 |
| Metric | DYN | MIAX |
|---|---|---|
| Price | $18.96 | $45.60 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 6 |
| Target Price | $40.00 | ★ $47.20 |
| AVG Volume (30 Days) | ★ 3.2M | 1.1M |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,318,535,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $19.04 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 22.86 |
| 52 Week Low | $6.36 | $28.63 |
| 52 Week High | $26.22 | $51.38 |
| Indicator | DYN | MIAX |
|---|---|---|
| Relative Strength Index (RSI) | 45.34 | N/A |
| Support Level | $18.43 | N/A |
| Resistance Level | $21.00 | N/A |
| Average True Range (ATR) | 0.97 | 0.00 |
| MACD | -0.08 | 0.00 |
| Stochastic Oscillator | 20.23 | 0.00 |
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
Miami International Holdings Inc is a technology-driven leader in building and operating regulated financial marketplaces across multiple asset classes and geographies. Its MIAX Exchange marketplaces are enabled by its in-house built, proprietary technology. It maintains a broad portfolio of U.S. exchange and clearing licenses, in both securities and futures. The company operates markets across a diverse number of asset classes including options and cash equities as well as futures and options on futures.